My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Natco Pharma declines on profit booking
Jun 12,2017

Meanwhile, the S&P BSE Sensex was down 129.70 points or 0.41% at 31,132.36.

On the BSE, 22,000 shares were traded on the counter so far as against the average daily volumes of 35,699 shares in the past one quarter. The stock had hit a high of Rs 1,078 and a low of Rs 1,012.80 so far during the day. The stock had hit a record high of Rs 1,080 on 9 June 2017 and a 52-week low of Rs 494 on 20 June 2016.

The stock had outperformed the market over the past one month till 9 June 2017, advancing 19.76% compared with the Sensexs 4.44% rise. The stock had also outperformed the market over the past one quarter, gaining 37.05% as against the Sensexs 8.06% rise. The scrip had also outperformed the market over the past one year, surging 106.11% as against the Sensexs 16.81% rise.

The large-cap company has equity capital of Rs 34.86 crore. Face value per share is Rs 2.

Shares of Natco Pharma had surged 14.85% in the preceding seven trading sessions to settle at Rs 1,072.30 on Friday, 9 June 2017, from its closing of Rs 933.65 on 31 May 2017. The rally was triggered by the company reporting strong Q4 March 2017 earnings after market hours on 30 May 2017.

Natco Pharmas consolidated net profit spurted 181.4% to Rs 176.70 crore on 46.5% increase in net sales to Rs 577.80 crore in Q4 March 2017 over Q4 March 2016.

Natco Pharma manufactures generic dosage forms, bulk actives and intermediates for the Indian and international markets.

Powered by Capital Market - Live News

Cadila Healthcare gains after USFDA nod for antifungal drug
Jun 12,2017

The announcement was made on Saturday, 10 June 2017.

Meanwhile, the S&P BSE Sensex was down 156.59 points, or 0.50% to 31,105.47.

On the BSE, 61,000 shares were traded in the counter so far, compared with average daily volumes of 1.47 lakh shares in the past one quarter. The stock had hit a high of Rs 551.95 so far during the day, which is also a record high for the counter. The stock had hit a low of Rs 545.15 so far during the day. The stock hit a 52-week low of Rs 305.05 on 24 June 2016.

The stock had outperformed the market over the past one month till 9 June 2017, rising 9.92% compared with 3.34% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 23.43% as against Sensexs 8% rise. The scrip had also outperformed the market in past one year, rising 70.19% as against Sensexs 17.37% rise.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA, has received final approval from the US Food and Drug Administration (USFDA) to market Nystatin Topical Powder USP, 100,000 units per gram.

The drug will be produced at the Nesher Pharmaceuticals manufacturing facility located at St. Louis, MO, USA. Nystatin Topical Powder is an antifungal antibiotic used to treat skin infections caused by yeast.

The group now has more than 115 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since the commencement of the filing process in the financial year ended March 2004.

Cadila Healthcares consolidated net profit fell 32.2% to Rs 385.5 crore on 6.5% rise in net sales to Rs 2417.50 crore in Q4 March 2017 over Q4 March 2016.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

DGFT creates GST Facilitation Cell for exporters
Jun 12,2017

DGFT has constituted a GST facilitation cell in DGFT Headquarters to assist and advice exporters , trade and industry for smooth transition from present regime to GST regime w.e.f. 1st July 2017.The GST facilitation cell is headed by Mr Nikunj Kumar Srivastava, Add DGFT and comprises two other officers Mr Rakesh Kumar Joint DGFT(r.kumar73@nic.in), Mr Kaushlendra Pratap Singh Deputy DGFT(Kaushlendrap.singh@nic.in. Exporters can email their queries concerning GST and pertaining to FTP.

Similarly all regional offices of DGFT have constituted GST facilitation cell and the cell would headed by head of the regional office i.e. Add DGFT/ Joint DGFT with other two officers of the rank of Deputy DGFTor Asst DGFT.

Recently, DG, DGFT also convened a meeting of stakeholders (FIEO/ trade/ industry) on 9 th June to understand the issues being faced by them in GST system. These issues have been taken up with department of revenue and GSTN, who have informed that most of the issues have already been resolved.

Earlier, DGFT, jointly with FIEO, had also organised an outreach program on 2nd June, 2017 to educate the exporters about GST regime. This program was attended by large number of exporters. Shri Ajay Bhalla, Director General DGFT himself addressed the exporters and explained them about all aspects of GST including benefits that will accrue to them because of automatic and quick refund of all taxes paid on inputs. DG also responded to many queries of the exporters regarding various export promotion schemes, filing of GST returns and claiming refund. Shri Tejpal singh, Addl DG, DGEP and Shri Yoginder Garg commissioner customs were also present in the workshop, who made detailed presentation on GST.

It may be noted that earlier Department of Commerce had announced to align the mid-term review of Foreign Trade Policy with roll out of GST for the convenience of exporters and industry.

Powered by Capital Market - Live News

Gajanan Securities Services appoints director
Jun 12,2017

Gajanan Securities Services has appointed Chirag Tekriwal (Din: - 07828255) as Additional Director (Independent Director) w.e.f. 30 May 2017.

Powered by Capital Market - Live News

Gajanan Securities Services appoints company secretary and compliance officer
Jun 12,2017

Gajanan Securities Services has appointed Riddhi Kanodia bearing Membership No (ACS 33590) as company Secretary and compliance officer w.e.f. 30 May 2017.

Powered by Capital Market - Live News

Zydus Nesher Pharmaceutical gets approval for Nystatin Topical Powder
Jun 12,2017

Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received final approval from the USFDA to market Nystatin Topical Powder USP, 100000 units per gram. The drug will be produced at the Nesher Pharmaceuticals manufacturing facility located at St. Louis, USA. Nystatin Topic Powder is an antifungal antibiotic used to treat skin infections caused by yeast.

Powered by Capital Market - Live News

Board of Viji Finance recommends bonus issue in ratio of 1:10
Jun 12,2017

Viji Finance announced that the Board of Directors of the Company at its meeting held on 10 June 2016, inter alia, has recommend issue of Bonus Shares in ratio of 1:10 i.e. 1 (One) bonus equity share having face value of Rs. 1/- each for every 10 (Ten) existing Fully paid up equity share having face value of Rs. 1/- each, to the shareholder of the Companywho held shares as on the Record Date, subject to the Approval of member in the ensuing 23rd Annual general Meeting of the Company.

Powered by Capital Market - Live News

Mawana Sugars surges after reporting good Q4 earnings
Jun 12,2017

The result was announced after market hours on Friday, 9 June 2017.

Meanwhile, the S&P BSE Sensex was down 153.10 points, 0.49% at 31,108.96. The S&P BSE Small-Cap index was down 38.33 points, 0.25% at 15,510.84.

On the BSE, 91,000 shares were traded on the counter so far as against the average daily volumes of 68,431 shares in the past one quarter. The stock had hit a high of Rs 85.50 and a low of Rs 81.35 so far during the day. The stock had hit a 52-week high of Rs 99 on 23 May 2017 and hit a 52-week low of Rs 34.65 on 17 November 2016.

The stock had underperformed the market over the past one month till 9 June 2017, declining 13.84% compared with the Sensexs 4.44% rise. The scrip had also underperformed the market over the past one quarter declining 11.26% as against the Sensexs 8.06% rise. The scrip had, however, outperformed the market over the past one year advancing 38.35% as against the Sensexs 16.81% rise.

The small-cap company has equity capital of Rs 39.12 crore. Face value per share is Rs 10.

Mawana Sugars in engaged in the manufacturing of some of the finest sugars in the country.

Powered by Capital Market - Live News

Board of Amtek Auto approves preferential issue of equity shares
Jun 12,2017

The Board of Directors of Amtek Auto at its meeting held on 10 June 2017 has approved the issuance of 268,33,876 Equity shares on Preferential basis to Assets Care & Reconstruction Enterprise at issue price of Rs 35.50 per share upon conversion of its unsecured loan.

Powered by Capital Market - Live News

Arcotech fixed record date for stock split
Jun 12,2017

The Board of Directors of Arcotech has fixed 23 June 2017 as the record date for the purpose of ascertaining the eligibility of the shareholders entitled for equity shares of the face value of Rs. 2/- each in lieu of the equity shares of the face value of Rs. 10/- each after the sub-division of the face value of the same as approved by the shareholders of the Company in the Extraordinary General Meeting held on 10 June 2017.

Powered by Capital Market - Live News

Atlas Jewellery India appoints director
Jun 12,2017

Atlas Jewellery India announced the appointment of Mandira Mutum, Executive Director- Quality & HR as Whole Time Director (KMP) of the Company w.e.f. 10 June 2017.

Powered by Capital Market - Live News

Amtek Auto drops after weak Q4 results
Jun 12,2017

The result was announced on Saturday, 10 June 2017.

Meanwhile, the S&P BSE Sensex was down 128.71 points or 0.41% at 31,133.35. The S&P BSE Small-Cap index declined 25.91 points or 0.17% at 15,523.26.

On the BSE, 47,000 shares were traded on the counter so far as against the average daily volumes of 5.81 lakh shares in the past one quarter. The stock had hit a high of Rs 35 and a low of Rs 34.25 so far during the day. The stock had hit a 52-week high of Rs 56.20 on 26 July 2016 and a 52-week low of Rs 30.60 on 27 December 2016.

The stock had underperformed the market over the past one month till 9 June 2017, sliding 10.94% compared with the Sensexs 4.44% rise. The stock had also underperformed the market over the past one quarter, declining 1.96% as against the Sensexs 8.06% rise. The stock had also underperformed the market over the past one year, gaining 0.57% as against the Sensexs 16.81% rise.

The small-cap company has equity capital of Rs 49.65 crore. Face value per share is Rs 2.

Amtek Autos total revenue declined 31.08% to Rs 448.45 crore in Q4 March 2017 over Q4 March 2016.

Amtek Auto is one of the leading integrated auto component manufacturers.

Powered by Capital Market - Live News

Mylan and Biocon present clinical data on Insulin Glargine
Jun 12,2017

Mylan and Biocon announced the presentation of new data from the insulin glargine clinical program, including the INSTRIDE studies at the American Diabetes Associations 77th Scientific Sessions in San Diego. The studies confirmed the efficacy, safety and immunogenicity of MYL-1501D, insulin glargine, in comparision to Lantus in patients with Type 1 and Type 2 diabetes. Data demonstrating pharmacokinetic and pharmacodynamic equivalence was also presented.

Insulin glargine is a long acting insulin used to treat adults with Type 2 diabetes, as well as adults and paediatric patients with Type 1 diabetes, for the control of high blood sugar.

Powered by Capital Market - Live News

Tata Motors slips after weak global wholesales in May
Jun 12,2017

The announcement was made after market hours on Friday, 9 June 2017.

Meanwhile, the S&P BSE Sensex was down 111.44 points, or 0.36% to 31,150.62.

On the BSE, 50,000 shares were traded in the counter so far, compared with average daily volumes of 5.58 lakh shares in the past one quarter. The stock had hit a high of Rs 467 and a low of Rs 459.65 so far during the day. The stock hit a 52-week high of Rs 598.60 on 7 September 2016. The stock hit a 52-week low of Rs 417.10 on 8 May 2017.

The stock had outperformed the market over the past one month till 9 June 2017, rising 9.31% compared with 3.34% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 0.37% as against Sensexs 8% rise. The scrip had also underperformed the market in past one year, rising 2.19% as against Sensexs 17.37% rise.

The large-cap company has equity capital of Rs 577.47 crore. Face value per share is Rs 2.

On a consolidated basis, net profit of Tata Motors declined 16.79% to Rs 4336.43 crore on 2.88% decline in net sales to Rs 77217.19 crore in Q4 March 2017 over Q4 March 2016.

Tata Motors is a market leader in commercial vehicles in India. The companys British luxury unit Jaguar Land Rover (JLR) sells premium luxury cars.

Powered by Capital Market - Live News

Bank stocks drop in early trade
Jun 12,2017

The S&P BSE Sensex was down 102.17 points or 0.33% at 31,159.89. The S&P BSE Bankex index declined 112.45 points or 0.42% at 26,707.83.

Among public sector banks, Punjab National Bank (down 0.95%), Bank of India (down 0.84%), Union Bank of India (down 0.82%), State Bank of India (down 0.73%), IDBI Bank (down 0.42%), Bank of Baroda (down 0.37%) and Indian Bank (down 0.57%) edged lower. Indian Overseas Bank (up 1.57%) and Corporation Bank (up 0.68%) edged higher.

Among private sector banks, RBL Bank (down 0.8%), Yes Bank (down 0.69%), ICICI Bank (down 0.56%), IndusInd Bank (down 0.47%), Axis Bank (down 0.15%) and HDFC Bank (down 0.08%) edged lower. Kotak Mahindra Bank (up 0.47%) edged higher.

Finance Minister Arun Jaitley will meet heads of public sector banks (PSU banks) today, 12 June 2017 to discuss the issue of non-performing assets (NPAs) and the steps being taken by them to expedite the recovery of bad loans. Major issues on the agenda of the meeting include issues and solutions relating to NPAs of the PSU banks, status of MSE Credit, Stand-up India and Mudra Yojana among others.

Oriental Bank of Commerce (OBC) was down 0.53%. The bank said it has revised the marginal cost of funds based lending rate (MCLR) for different tenors with effect from 12 June 2017. The banks MCLR for overnight loans will be 8.1%, the rate for one month will be 8.2% and for three months it will be 8.25%. The MCLR on 6-month loans will be 8.35% and for one-year loans the rate will be 8.5%, the bank said. The announcement was made after market hours on Friday, 9 June 2017.

The S&P BSE Bankex index had underperformed the market over the past one month till 9 June 2017, advancing 3.83% compared with the Sensexs 4.44% rise. The index had, however, outperformed the market over the past one quarter, gaining 13.51% as against the Sensexs 8.06% rise. The index had also outperformed the market over the past one year, gaining 30.81% as against the Sensexs 16.81% rise.

Powered by Capital Market - Live News